A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease
Authors
Keywords
-
Journal
JOURNAL OF INTERVENTIONAL CARDIOLOGY
Volume 29, Issue 3, Pages 241-247
Publisher
Wiley
Online
2016-06-01
DOI
10.1111/joic.12293
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complete Versus Culprit-Only Revascularization for ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: A Meta-Analysis and Trial Sequential Analysis of Randomized Trials
- (2015) S. Bangalore et al. Circulation-Cardiovascular Interventions
- Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials
- (2015) Islam Y. Elgendy et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease
- (2015) Anthony H. Gershlick et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
- (2015) Thomas Engstrøm et al. LANCET
- Fractional Flow Reserve: An Updated Review
- (2014) Islam Y. Elgendy et al. CLINICAL CARDIOLOGY
- Randomized Trial of Preventive Angioplasty in Myocardial Infarction
- (2013) David S. Wald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation
- (2012) G. De Luca et al. DIABETES CARE
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) Patrick T. O'Gara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction
- (2011) Ran Kornowski et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction
- (2011) Pieter J. Vlaar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial
- (2010) M. Toma et al. EUROPEAN HEART JOURNAL
- Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
- (2010) Edward L. Hannan et al. JACC-Cardiovascular Interventions
- Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?
- (2010) Jan-Henk Dambrink et al. EuroIntervention
- Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction
- (2009) Thao Huynh et al. CIRCULATION
- Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES
- (2009) Giuseppe De Luca et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Culprit only versus complete coronary revascularization during primary PCI
- (2007) Dahud Qarawani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started